Cancer Medicine Journal Issues Research Articles in Part 2 of May 2020 Edition
May 15, 2020
May 15, 2020
MEDFORD, Massachusetts, May 15 -- Cancer Medicine, a peer-reviewed journal that says it features research from biomedical researchers across the cancer sciences, published research articles, including the following topics, in Part 2 of its May 2020 edition:
* Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation
* Delayed presentation, diagno . . .
* Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation
* Delayed presentation, diagno . . .